Connect with us

World News

Brazil Probes Hospital Chain Over Medicine Bolsonaro Treats Hydroxychloroquine as a Cure for Covid

Published

on


President Jair Bolsonaro advocated the anti-malarial drug hydroxychloroquine as a treatment for Covid.

Brasilia:

Brazil’s agency that regulates health insurance plans has launched an investigation into allegations that a hospital chain tested unproven drugs on elderly COVID-19 patients without their knowledge, the regulator’s director told a senate on Wednesday. told in the investigation.

It was the first instance of a regulatory agency looking into misdemeanors at Prevent Senior, a major healthcare chain serving thousands of patients in the So Paulo area.

Paulo Rebelo Filho, head of the national regulatory agency for private health insurance plans (ANS), said his staff had detected “aid abnormalities” in Prevent Senior and the health chain would be placed under special technical supervision.

At least nine people died of COVID-19 during trials at Prevent Senior from March to April 2020, but their charts were altered to hide the cause of death, 10 whistleblowing doctors last week Was told during interrogation by the lawyer of.

Senators were told the hospital chain had sought to validate far-right President Jair Bolsonaro’s policy of advocating for the anti-malarial drug hydroxychloroquine as a treatment for COVID patients.

Prevent Senior has said that the allegations, including changing the chart of patients and dismissal of doctors who opposed the practice, are baseless.

Rebello said the ANS has opened an administrative process to investigate irregularities at Prevent Sr. and sent officers to verify “signs of operational failures”.

He said the objective of close monitoring is not to remove the hospital chain from the market, but to guarantee the maintenance of quality care.

The regulatory chief said he had no idea about the allegations made by the doctors until they appeared in a Senate inquiry.

Prevent Sr. said in a statement that it has not been officially informed of the ANS’s decision. It said it has provided documents to the regulator to show that it has acted within ethical and regulatory norms.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

.

Copyright Indian Lekhak Limited 2021. All Rights Reserved